10.1016/j.ymgme.2007.04.011 142 SinghalN
Updated October 28, 2025 Reviewed by Michelle Quirk Key points GLP-1 drugs show potential to treat substance use disorders
A, Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R
NAD+ is one of the most important co-factors for improving mitochondrial function the process by which cells convert micronutrients into ATP, the bodys primary energy source
By PharmaCompass 2025-09-04 Impressions: 1,267 Article || 136 Video Novartis signed two deals this week a US$ 5.2 billion cardiology deal with Chinas Argo Biopharmaceuticals, and a US$ 2 billion deal with Arrowhead Pharmaceuticals for its preclinical therapy aimed at treating neurodegenerative diseases such as Parkinsons
Earlier this year, the brands Hold my Oikos Super Bowl ad featured ESPN host and former NFL player Shannon Sharpe with actor Martin Lawrence